The FY2025 filing reveals a company at a crossroads between an efficient retail machine and a fragile financial structure. On one hand, the growth of the health services segment and the dominance of the Autoship model provide a compelling case for long-term platform dominance. On the other, the disparity between Adjusted EBITDA and GAAP net income highlights a reliance on accounting adjustments to present a narrative of profitability.
Investors must weigh the genuine operational progress—such as the expansion to 18 veterinary clinics and improved fulfillment efficiency—against the systemic risks of lease-heavy capital structures and vendor concentration. The ultimate trajectory of the stock will likely depend on whether Chewy can transition its customers from discount-driven loyalty to service-driven loyalty, effectively moving the needle on GAAP margins without further eroding its cash reserves through buybacks.